Simple animal models for amyotrophic lateral sclerosis drug discovery. - RIIP - Réseau International des Instituts Pasteur Accéder directement au contenu
Article Dans Une Revue Expert Opinion on Drug Discovery Année : 2016

Simple animal models for amyotrophic lateral sclerosis drug discovery.

Résumé

Simple animal models have enabled great progress in uncovering the disease mechanisms of amyotrophic lateral sclerosis (ALS) and are helping in the selection of therapeutic compounds through chemical genetic approaches. Within this article, the authors provide a concise overview of simple model organisms, C. elegans, Drosophila and zebrafish, which have been employed to study ALS and discuss their value to ALS drug discovery. In particular, the authors focus on innovative chemical screens that have established simple organisms as important models for ALS drug discovery. There are several advantages of using simple animal model organisms to accelerate drug discovery for ALS. It is the authors' particular belief that the amenability of simple animal models to various genetic manipulations, the availability of a wide range of transgenic strains for labelling motoneurons and other cell types, combined with live imaging and chemical screens should allow for new detailed studies elucidating early pathological processes in ALS and subsequent drug and target discovery.
Fichier non déposé

Dates et versions

pasteur-01351530 , version 1 (03-08-2016)

Identifiants

Citer

Shunmoogum A Patten, J Alex Parker, Xiao-Yan Wen, Pierre Drapeau. Simple animal models for amyotrophic lateral sclerosis drug discovery.. Expert Opinion on Drug Discovery, 2016, 11 (8), pp.797-804. ⟨10.1080/17460441.2016.1196183⟩. ⟨pasteur-01351530⟩

Collections

RIIP INRS-IAF
18 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More